GalenOps prod · 0.1.0

Patient

SITE004-0084

completed Phase III

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE004 (DEU) (Dr. Tanaka)

consented 2025-12-01

SITE004 (DEU)

Adverse events

9

Serious AEs

0

Open data queries

0

Luna dropout signal

—

not on Luna

Adverse events 9

moderate assessed 2026-03-06

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-08-30 (study day 81); relationship: NOT RELATED

moderate assessed 2026-02-01

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-28 (study day 48); relationship: NOT RELATED

severe assessed 2026-01-27

Grade 3 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-23 (study day 43); relationship: NOT RELATED

mild assessed 2026-01-22

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-07-18 (study day 38); relationship: NOT RELATED

mild assessed 2026-01-02

Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2022-06-28 (study day 18); relationship: not assessed

moderate assessed 2025-12-28

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-06-23 (study day 13); relationship: NOT RELATED

moderate assessed 2025-12-22

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-06-17 (study day 7); relationship: not assessed

mild assessed 2025-12-20

Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2022-06-15 (study day 5); relationship: RELATED

moderate assessed 2025-12-18

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-06-13 (study day 3); relationship: not assessed

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users